All In Biotech

Drug Trial Radar · NCT04752371

A Study to Evaluate Camoteskimab in Participants With Still's Disease

A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Camoteskimab in Subjects With Adult Onset Still's Disease

Last checked: Nov 19, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

5

Actual

Start

Mar 25, 2021

Primary completion

May 24, 2022

Study completion May 24, 2022

Sponsor

Lead sponsor
Apollo Therapeutics LtdIndustry
Sponsor type
Industry
First posted
Feb 12, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease.

Conditions

  • Adult Onset Still's Disease

Interventions

  • Camoteskimab (CERC-007, AVTX-007, AEVI-007)Drug

    Intravenous (IV) Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of AEsTime frame: Baseline to Week 24
  2. Incidence of Clinically Significant Changes from Baseline in Vital SignsTime frame: Baseline to Week 24
  3. Incidence of Clinically Significant Changes from Baseline in Clinical Laboratory ResultsTime frame: Baseline to Week 24

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Sponsor Investigative Site

    Gainesville, Florida

  • Sponsor Investigative Site

    Ann Arbor, Michigan

  • Sponsor Investigative Site

    Ghent, Oost-Vlaanderen, Belgium

  • Sponsor Investigative Site

    Elblag, Poland

  • Sponsor Investigative Site

    Pomorskie, Poland

  • Sponsor Investigative Site

    Poznan, Poland

  • Sponsor Investigative Site

    Poznan, Poland

  • Sponsor Investigative Site

    Kyiv, Ukraine

  • Sponsor Investigative Site

    Poltava, Ukraine

  • Sponsor Investigative Site

    Ternopil, Ukraine

  • Sponsor Investigative Site

    Vinnitsa, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.